We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
1776
PUT
Best Buy
BBY
$18.3B
$4.99M ﹤0.01%
63,700
-14,500
-19% -$1.02M
SDRL icon
1777
Seadrill
SDRL
$2.91B
$4.96M ﹤0.01%
+104,946
New +$4.45M
PECO icon
1778
Phillips Edison & Co
PECO
$5.12B
$4.96M ﹤0.01%
135,997
+38,339
+39% +$1.34M
CHTR icon
1779
Charter Communications
CHTR
$18.4B
$4.96M ﹤0.01%
12,761
-10,885
-46% -$4.44M
DORM icon
1780
Dorman Products
DORM
$3.87B
$4.96M ﹤0.01%
59,445
-7,171
-11% -$536K
SEE
1781
CALL
DELISTED
Sealed Air
SEE
$4.96M ﹤0.01%
135,700
+23,900
+21% +$784K
HMY icon
1782
Harmony Gold Mining
HMY
$14.1B
$4.94M ﹤0.01%
803,456
+309,507
+63% +$1.63M
AKRO
1783
DELISTED
Akero Therapeutics
AKRO
$4.93M ﹤0.01%
210,960
+74,062
+54% +$1.46M
SLF icon
1784
CALL
Sun Life Financial
SLF
$44.3B
$4.93M ﹤0.01%
95,000
+45,000
+90% +$2.21M
ENSG icon
1785
The Ensign Group
ENSG
$10.5B
$4.92M ﹤0.01%
43,850
+40,328
+1,145% +$4.17M
GTES icon
1786
Gates Industrial Corp
GTES
$6.78B
$4.91M ﹤0.01%
366,074
-718,607
-66% -$8.5M
PBA icon
1787
PUT
Pembina Pipeline
PBA
$28.2B
$4.9M ﹤0.01%
142,500
+62,500
+78% +$2M
WBD icon
1788
Warner Bros
WBD
$72.4B
$4.9M ﹤0.01%
430,917
-1,083,524
-72% -$11.7M
MTUS icon
1789
Metallus
MTUS
$810M
$4.9M ﹤0.01%
208,878
-6,821
-3% -$143K
MTW icon
1790
Manitowoc
MTW
$709M
$4.89M ﹤0.01%
292,755
-34,683
-11% -$505K
MLM icon
1791
Martin Marietta Materials
MLM
$38.4B
$4.88M ﹤0.01%
9,783
-43,724
-82% -$19.7M
TOL icon
1792
Toll Brothers
TOL
$14B
$4.88M ﹤0.01%
47,483
-126,765
-73% -$10.6M
OMER icon
1793
Omeros
OMER
$1.37B
$4.88M ﹤0.01%
1,492,303
+130,867
+10% +$276K
CFLT
1794
DELISTED
Confluent
CFLT
$4.87M ﹤0.01%
207,907
-497,988
-71% -$12M
AMSC icon
1795
American Superconductor
AMSC
$1.45B
$4.85M ﹤0.01%
435,744
+61,616
+16% +$521K
ROAD icon
1796
Construction Partners
ROAD
$6.43B
$4.84M ﹤0.01%
111,099
+23,105
+26% +$947K
TASK icon
1797
TaskUs
TASK
$718M
$4.83M ﹤0.01%
369,220
+217,940
+144% +$2.41M
AGIO icon
1798
Agios Pharmaceuticals
AGIO
$2.03B
$4.82M ﹤0.01%
216,484
+58,204
+37% +$1.3M
PHM icon
1799
CALL
Pultegroup
PHM
$25B
$4.82M ﹤0.01%
46,700
-8,300
-15% -$705K
LPSN icon
1800
LivePerson
LPSN
$34.2M
$4.82M ﹤0.01%
84,700
-31,845
-27% -$1.47M

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.